Patent ID: 9504729
Filing Date: 2016-11-29
CPC Classification: A61K,A61P

Claim Text:
1. A method of ameliorating an angiogenesis-dependent disease, comprising: administering to a subject having an angiogenesis-dependent disease a therapeutically effective amount of a composition comprising at least one of (2,5-dioxopyrrol-1-yl)methyl propanoate (NSC 19630), 1-benzylsulfonyl-2,4-dinitrobenzene (NSC 122657), maytansinol isobutyrate (NSC 292222), chloroplatinum(1+); 2-(4-methylpiperidin-1-yl)ethanethiolate; dihydrate (NSC 292596), or a pharmaceutically acceptable salt thereof.